Carbetapentane tannate 6 mg/ML / diphenhydramine tannate 5 mg/ML Extended Release Suspension [Dytan-AT]
RxNorm 1297544
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1297544 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: carbetapentane tannate 6 mg/ML / diphenhydramine tannate 5 mg/ML Extended Release Suspension [Dytan-AT].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Carbetapentane tannate 6 mg/ML / diphenhydramine tannate 5 mg/ML Extended Release Suspension [Dytan-AT]
(Atom ID: 12368277)
TMSY
Tall Man Lettering Synonym (TMSY):
Carbetapentane tannate 6 mg/ML / diphenhydrAMINE tannate 5 mg/ML Extended Release Suspension [Dytan-AT]
(Atom ID: 12385552)
SY
Synonym (SY):
Dytan-AT (carbetapentane tannate 30 mg / diphenhydramine tannate 25 mg) per 5 mL Extended Release Suspension
(Atom ID: 4618795)
TMSY